AI-generated summary
The authors studied photobiomodulation at 904 nm in adult male rats with streptozotocin-induced type 1 diabetes, examining mitochondrial dynamics in peripheral nerves. They report that the treatment modulated expression of mitofusin 2 and dynamin-related protein 1 in the sciatic nerve and dorsal root ganglia neurons. The authors suggest a possible role in preventing or reversing mitochondrial dysfunction, but this is an animal study.
- Who or what was studied
- Adult male rats with streptozotocin-induced type 1 diabetes
- Wavelengths
- 904 nm
- Limits stated in the abstract
- The study was conducted in an animal model, so the findings may not apply directly to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 904 nm
- Energy density (fluence)
- 6.23 J/cm2
- Power
- 45 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Neuropathy, Mitochondria. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.